Literature DB >> 10844968

Prevalence of pituitary tumors among diabetic cats with insulin resistance.

D A Elliott1, E C Feldman, P D Koblik, V F Samii, R W Nelson.   

Abstract

OBJECTIVE: To determine prevalence of pituitary tumors, detectable by means of computed tomography or magnetic resonance imaging, in cats with insulin resistance suspected to have acromegaly or hyperadrenocorticism versus cats with well-controlled diabetes mellitus.
DESIGN: Case series. ANIMALS: 16 cats with insulin resistance that were also suspected to have acromegaly (n = 12) or pituitary-dependent hyperadrenocorticism (4) and 8 cats with well-controlled diabetes mellitus. PROCEDURE: Computed tomography was performed on all 16 cats with insulin resistance and 2 cats in which diabetes mellitus was well-controlled. The remaining 6 cats in which diabetes mellitus was well-controlled underwent magnetic resonance imaging. Images were obtained before and immediately after i.v. administration of contrast medium.
RESULTS: Computed tomography revealed a mass in the region of the pituitary gland in all 16 cats with insulin resistance. Maximum width of the masses ranged from 4.4 to 12.7 mm; maximum height ranged from 3.1 to 12.6 mm. Results of computed tomography performed on 2 cats with well-controlled diabetes and magnetic resonance imaging performed on the remaining 6 cats were considered normal. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that cats with insulin resistance suspected to have acromegaly or pituitary-dependent hyperadrenocorticism are likely to have a pituitary mass detectable by means of computed tomography or magnetic resonance imaging.

Entities:  

Mesh:

Year:  2000        PMID: 10844968     DOI: 10.2460/javma.2000.216.1765

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Authors:  Francesco Zublena; Alice Tamborini; Carmel T Mooney; Susan M North; Monika A Lobacz; Dan Andrew; Vanessa Woolhead; Heather Covey; Herbert A Schmid; David B Church; Stijn J M Niessen
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Acromegaly in a non-diabetic cat.

Authors:  Federico Fracassi; Margherita Salsi; Federica Sammartano; Stefano Bo; Hans S Kooistra
Journal:  JFMS Open Rep       Date:  2016-04-25

3.  Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.

Authors:  Tiffany L Wormhoudt; Mary-Keara Boss; Katharine Lunn; Lynn Griffin; Del Leary; Kristy Dowers; Sangeeta Rao; Susan M LaRue
Journal:  J Vet Intern Med       Date:  2018-05-21       Impact factor: 3.333

4.  Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.

Authors:  J M Fletcher; C J Scudder; M Kiupel; H N Pipe-Martin; P J Kenny; P Mantis; J Fenn; K Smith; R V Blair; L A Granger; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-06-03       Impact factor: 3.333

5.  Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.

Authors:  S V Keyte; P J Kenny; Y Forcada; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

6.  Long-term management and postmortem examination in a diabetic cat with acromegaly treated with two courses of radiation therapy.

Authors:  Harumi Sawada; Akihiro Mori; Masaki Michishita; Hitomi Oda; Toshinori Sako
Journal:  J Vet Med Sci       Date:  2018-11-16       Impact factor: 1.267

7.  Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.

Authors:  Kirsten L van Bokhorst; Sara Galac; Hans S Kooistra; Chiara Valtolina; Federico Fracassi; Dan Rosenberg; Björn P Meij
Journal:  J Vet Intern Med       Date:  2021-02-23       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.